Advances in Cancer Research

By

  • George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA

The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics, including HAMLET and tumor cells; survivin and apoptosis control; retroviral insertional mutagenesis; aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis; and epigenetic variability and the evolution of human cancer.
View full description

Audience

Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.

 

Book information

  • Published: March 2003
  • Imprint: ACADEMIC PRESS
  • ISBN: 978-0-12-006688-9

Reviews

"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences" -AMERICAN SCIENTIST "Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced." -JOURNAL OF MEDICINAL CHEMISTRY "This is a series that has a long tradition of excellence in the field of cancer biology." -DOODY'S PUBLISHING REVIEWS



Table of Contents

HAMLET Kills Tumor Cells by Apoptosis - Cellular, Molecular and Therapeutic Aspects; Survivin and Apoptosis Control; Retroviral Insertional Mutagenesis: Tagging Cancer Pathways; Aberrant Ubiquitin-Mediated Proteolysis of Cell Cycle Regulatory Proteins and Oncogenesis; Epigenetic Variability and the Evolution of Human Cancer